Exploring Leveraging Adult Efficacy Data For Pediatrics Using Bridging Biomarkers
Exploring Leveraging Adult Efficacy Data For Pediatrics Using Bridging Biomarkers reveals several interesting facts.
- Disease heterogeneity creates heterogeneity in patients' treatment responsiveness, which in turn drives up clinical trial size, time, ...
- Pediatric
- Hector Wong, MD, Vice Chair of the Department of
- Biomarker
- Presentation Title: Development and validation of cerebrospinal fluid and blood
In-Depth Information on Leveraging Adult Efficacy Data For Pediatrics Using Bridging Biomarkers
Presentation Title: Clinical Translational Science: In this video, Dr. Nadir Yehya, Assistant Professor of Anesthesiology and Critical Care Medicine at the This video is from the PICC World Congress from June 2016 where Dr. Wong talks about Day 1, Session 1, Part 1 – Evidence to support
Video abstract of a review paper “Prognostic scores and
Stay tuned for more updates related to Leveraging Adult Efficacy Data For Pediatrics Using Bridging Biomarkers.
